The impact of ESG performance on corporate innovation-Empirical evidence from Chinese pharmaceutical listed companies.

ABSTRACT: Environmental, social and governance performance is an important driver for companies to achieve innovative and high-quality development, and the relationship between sustainable development and corporate innovation is one of the key concerns of pharmaceutical companies. This study aims to reveal the intrinsic role mechanism of sustainable transformation of pharmaceutical enterprises in high-quality innovation development. Based on the relevant data of China's A-share pharmaceutical listed companies from 2015 to 2022, the study establishes a fixed effect model and a mediation effect model, empirically examines the impact of ESG performance on the innovation of pharmaceutical listed companies, and deeply explores the role mechanism of R&D personnel investment and government subsidies in it.

SUBMITTER: Li L 

PROVIDER: S-EPMC12585053 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature